Results 111 to 120 of about 2,408 (176)

Lipoprotein A and the Association With Peripheral Arterial Disease: A Review of the Risk in Peripheral Arterial Disease. [PDF]

Rev Cardiovasc Med
Kar S.
europepmc   +1 more source

From Risk to Resilience: Transforming Perinatal Management for Women with FH. [PDF]

J Atheroscler Thromb
Ogura M.
europepmc   +1 more source

Cholesterol Levels Are Not Associated with Peripheral Blood Stem Cell Mobilization in Healthy Donors. [PDF]

J Clin Med
Seçilmiş S, Aslan Candır B, Bozan E, Yaman S, Uncu Ulu B, Yiğenoğlu TN, İskender D, Kızıl Çakar M, Dal MS, Altuntaş F.   +9 more
europepmc   +1 more source

Liver transplantation for homozygous familial hypercholesterolaemia. [PDF]

Curr Opin Lipidol
Thompson GR, Walji S, Cegla J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hypercholesterolemia and LDL Apheresis

The International Journal of Artificial Organs, 2005
Several trials have assessed the link between low-density lipoprotein cholesterol (LDL) and the development of coronary heart disease (CHD). LDL apheresis provides an effective role in treating patients with familial hypercholesterolemia (FH) and in preventing the progression of coronary artery disease (CAD).
F. Morelli, P. Carlier, G. Giannini, M.C. De Luigi, A. Dejana, M.R. Ruzzenenti, M. Valbonesi   +6 more
openaire   +2 more sources

Immunosorbents for LDL-Apheresis

Biomaterials, Artificial Cells and Artificial Organs, 1990
Low density lipoprotein (LDL) (1,03-1,05 g/ml) was utilized as antigen to obtain polyclonal (PcAb) and monoclonal (McAb) antibodies. Immunosorbents capable of selective removing LDL from human plasma were developed on the basis of the antibodies preparation.
S N, Pokrovsky, , Adamova IYu, G F, Benevolenskaya   +2 more
openaire   +2 more sources

LDL apheresis in Japan

Transfusion and Apheresis Science, 2017
LDL apheresis has been developed as the treatment for refractory familial hypercholesterolemia (FH). Currently, plasma exchange, double membrane filtration, and selective LDL adsorption are available in Japan, and selective LDL adsorption is most common method. LDL apheresis can prevent atherosclerosis progression even in homozygous (HoFH). However, in
Hisashi, Makino, Tamiko, Tamanaha, Mariko, Harada-Shiba   +2 more
openaire   +2 more sources

The Dresden Apheresis Center – experience with LDL apheresis and immunoadsorption

Atherosclerosis Supplements, 2009
The first apheresis center in former German Democratic Republic was established in Dresden November 1990 following the reunification of Germany. We here summarize the activities of this center to date. From the center's establishment until the end of July 2009 13,291 sessions of therapeutic apheresis have been performed.
Ulrich Julius, Sergey Tselmin, Jens Passauer   +2 more
exaly   +3 more sources